by Richard Daverman, PhD
April 29, 2013 -- Shanghai Fosun Pharma, Chindex and a private equity partner will spend up to $240 million to buy 95.6% of an Israeli medical device company, Alma Lasers. Alma, which had revenues of about $100 million last year, makes lasers and other products, primarily for aesthetic procedures. Fosun said the investment represented a growing internationalization of its operations. More details....
Stock Symbols: (SH: 600196; HK: 02196) (NSDQ: CHDX)
